Watchlist Manager

Watchlist

Price: 48 950 KRW 1.45% Market Closed

Market Cap: ₩2.6T

H	Hanall Biopharma Co Ltd KRX:009420	KR
	Goldman Sachs BDC Inc NYSE:GSBD	US
C	Century Ginwa Retail Holdings Ltd HKEX:162	HK
A	American Salars Lithium Inc OTC:ASALF	CA
	Nova Cannabis Inc TSX:NOVC	CA
	Geox SpA MIL:GEO	IT
F	Fuji Seal International Inc TSE:7864	JP

Income Statement

Currency: KRW

	Dec-2005	Mar-2006	Jun-2006	Sep-2006	Dec-2006	Mar-2007	Jun-2007	Sep-2007	Dec-2007	Mar-2008	Jun-2008	Sep-2008	Dec-2008	Mar-2009	Jun-2009	Sep-2009	Dec-2009	Mar-2010	Jun-2010	Sep-2010	Dec-2010	Mar-2011	Jun-2011	Sep-2011	Dec-2011	Mar-2012	Jun-2012	Sep-2012	Dec-2012	Mar-2013	Jun-2013	Sep-2013	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025	Dec-2025
Revenue
Interest Expense	944	1 016	1 098	1 195	1 221	1 260	1 285	1 374	1 532	1 744	1 750	1 764	2 004	2 326	2 781	3 250	3 426	3 433	0	0	4 064	1 054	0	0	3 475	0	0	614	2 371	1 613	0	1 276	1 374	747	981	955	989	997	996	947	680	0	0	0	0	0	0	0	0	0	0	0	0	6	8	10	14	11	13	13	16	16	20	25	25	0	23	21	22	35	45	54	64	70	68	71	71	73	78	81	143
Revenue	77 532 N/A	79 939 +3%	82 208 +3%	84 611 +3%	84 897 +0%	84 905 +0%	84 299 -1%	83 073 -1%	82 486 -1%	83 460 +1%	84 125 +1%	87 353 +4%	91 890 +5%	94 936 +3%	98 040 +3%	97 308 -1%	98 682 +1%	100 170 +2%	102 122 +2%	106 767 +5%	106 904 +0%	106 085 -1%	101 268 -5%	94 278 -7%	87 702 -7%	82 042 -6%	78 648 -4%	78 759 +0%	76 027 -3%	76 071 +0%	76 161 +0%	74 338 -2%	74 228 0%	76 276 +3%	77 511 +2%	78 763 +2%	80 880 +3%	81 656 +1%	81 891 +0%	79 817 -3%	80 023 +0%	79 447 -1%	79 584 +0%	82 223 +3%	82 882 +1%	80 419 -3%	80 421 +0%	84 029 +4%	84 231 +0%	87 204 +4%	89 131 +2%	88 551 -1%	91 839 +4%	94 252 +3%	101 531 +8%	105 550 +4%	108 452 +3%	106 049 -2%	98 834 -7%	92 953 -6%	88 602 -5%	94 304 +6%	95 140 +1%	98 500 +4%	101 594 +3%	97 783 -4%	100 596 +3%	104 764 +4%	109 995 +5%	114 812 +4%	129 981 +13%	133 308 +3%	134 910 +1%	140 199 +4%	130 374 -7%	134 245 +3%	138 944 +4%	141 000 +1%	150 089 +6%	154 053 +3%	155 185 +1%
Gross Profit
Cost of Revenue	(32 063)	(33 215)	(34 385)	(34 625)	(34 212)	(33 687)	(33 873)	(34 023)	(35 106)	(35 933)	(36 373)	(38 278)	(40 257)	(42 518)	(44 461)	(46 020)	(48 395)	(49 340)	(49 820)	(51 039)	(50 444)	(49 436)	(49 856)	(46 697)	(43 316)	(41 283)	(39 665)	(40 321)	(40 574)	(41 724)	(41 499)	(41 234)	(42 478)	(42 986)	(42 277)	(42 261)	(40 835)	(41 108)	(42 015)	(41 653)	(43 122)	(42 962)	(42 641)	(44 085)	(44 379)	(43 762)	(43 684)	(43 281)	(41 552)	(41 479)	(41 429)	(41 731)	(42 814)	(43 202)	(43 687)	(43 477)	(45 672)	(43 935)	(42 802)	(41 379)	(37 951)	(39 296)	(39 208)	(39 872)	(41 262)	(42 462)	(44 041)	(46 529)	(48 024)	(49 901)	(52 807)	(55 106)	(59 738)	(62 133)	(63 630)	(65 251)	(65 637)	(67 100)	(70 134)	(72 849)	(74 327)
Gross Profit	45 469 N/A	46 725 +3%	47 823 +2%	49 986 +5%	50 685 +1%	51 218 +1%	50 426 -2%	49 051 -3%	47 379 -3%	47 528 +0%	47 753 +0%	49 075 +3%	51 633 +5%	52 418 +2%	53 579 +2%	51 288 -4%	50 287 -2%	50 832 +1%	52 304 +3%	55 730 +7%	56 460 +1%	56 649 +0%	51 411 -9%	47 579 -7%	44 386 -7%	40 757 -8%	38 982 -4%	38 438 -1%	35 453 -8%	34 347 -3%	34 662 +1%	33 104 -4%	31 750 -4%	33 290 +5%	35 234 +6%	36 503 +4%	40 045 +10%	40 549 +1%	39 877 -2%	38 164 -4%	36 900 -3%	36 485 -1%	36 943 +1%	38 138 +3%	38 502 +1%	36 657 -5%	36 737 +0%	40 749 +11%	42 679 +5%	45 725 +7%	47 702 +4%	46 819 -2%	49 026 +5%	51 049 +4%	57 843 +13%	62 072 +7%	62 780 +1%	62 113 -1%	56 031 -10%	51 574 -8%	50 651 -2%	55 008 +9%	55 932 +2%	58 627 +5%	60 333 +3%	55 321 -8%	56 555 +2%	58 235 +3%	61 971 +6%	64 912 +5%	77 174 +19%	78 202 +1%	75 172 -4%	78 066 +4%	66 744 -15%	68 993 +3%	73 306 +6%	73 900 +1%	79 955 +8%	81 204 +2%	80 858 0%
Operating Income
Operating Expenses	(40 645)	(42 998)	(44 384)	(45 186)	(47 104)	(48 157)	(48 871)	(48 421)	(49 005)	(48 222)	(48 490)	(49 458)	(50 484)	(50 027)	(50 308)	(48 144)	(46 269)	(46 471)	(48 276)	(50 381)	(48 503)	(50 570)	(51 781)	(51 314)	(50 990)	(52 893)	(46 972)	(43 633)	(38 518)	(38 505)	(39 670)	(42 607)	(44 733)	(50 345)	(49 444)	(47 107)	(39 230)	(53 543)	(53 403)	(54 288)	(41 180)	(40 683)	(40 600)	(40 181)	(38 217)	(38 864)	(39 562)	(40 349)	(39 139)	(43 484)	(44 112)	(43 085)	(43 552)	(47 774)	(44 695)	(46 524)	(45 690)	(44 733)	(44 041)	(43 083)	(44 717)	(46 566)	(47 533)	(49 053)	(50 233)	(51 209)	(53 333)	(56 598)	(60 466)	(64 552)	(69 374)	(70 933)	(72 961)	(73 998)	(73 876)	(75 765)	(73 076)	(74 129)	(76 035)	(77 365)	(81 774)
Selling, General & Administrative	(37 315)	(39 272)	(40 611)	(41 362)	(43 238)	(44 254)	(44 572)	(43 625)	(43 616)	(41 868)	(41 554)	(42 681)	(43 638)	(43 357)	(43 877)	(41 331)	(39 774)	(40 754)	(43 370)	(46 782)	(42 057)	(48 571)	(49 278)	(48 604)	(42 965)	(51 065)	(46 244)	(42 091)	(30 162)	(31 963)	(33 128)	(34 744)	(34 646)	(36 985)	(33 509)	(32 353)	(30 589)	(31 347)	(32 049)	(32 952)	(34 286)	(29 412)	(28 986)	(27 376)	(28 405)	(28 677)	(28 294)	(27 785)	(28 593)	(28 480)	(28 677)	(29 948)	(32 399)	(33 229)	(34 755)	(35 610)	(34 978)	(34 866)	(34 638)	(34 431)	(34 754)	(36 083)	(37 066)	(38 142)	(39 158)	(39 542)	(40 460)	(42 090)	(43 327)	(44 591)	(45 368)	(46 580)	(48 373)	(50 071)	(51 352)	(51 887)	(52 485)	(53 793)	(56 103)	(58 620)	(61 862)
Research & Development	(2 355)	(2 708)	(2 807)	(2 822)	(2 832)	(2 864)	(3 211)	(3 715)	(4 674)	(5 713)	(6 427)	(6 356)	(6 279)	(6 127)	(5 932)	(6 376)	(6 070)	(5 776)	0	0	(6 590)	(1 561)	0	0	(7 532)	0	0	(1 292)	(7 925)	(6 083)	0	(7 385)	(9 507)	(6 910)	(9 273)	(8 025)	(7 795)	(7 489)	(6 586)	(6 571)	(6 066)	(10 383)	(10 794)	(11 987)	(9 003)	(9 386)	(10 210)	(11 790)	(9 790)	(11 837)	(12 308)	(10 122)	(10 545)	(9 400)	(9 295)	(10 263)	(10 051)	(9 279)	(8 769)	(8 018)	(9 316)	(9 789)	(9 783)	(10 238)	(10 462)	(11 089)	(12 236)	(13 877)	(16 498)	(19 276)	(23 374)	(23 701)	(23 603)	(23 304)	(21 898)	(23 280)	(19 993)	(19 778)	(19 302)	(18 131)	(19 315)
Depreciation & Amortization	(974)	(1 019)	(966)	(1 001)	(1 035)	(1 039)	(1 088)	(1 082)	(715)	(640)	(508)	(420)	(567)	(543)	(498)	(436)	(425)	(407)	0	0	(502)	(122)	0	0	(493)	0	0	(108)	(430)	(332)	0	(367)	(580)	(543)	(755)	(822)	(846)	(841)	(836)	(833)	(828)	(822)	(818)	(815)	(809)	(800)	(787)	(777)	(756)	(739)	(699)	(659)	(608)	(671)	(645)	(650)	(662)	(588)	(633)	(634)	(645)	(648)	(638)	(628)	(613)	(578)	(637)	(632)	(641)	(686)	(632)	(651)	(985)	(622)	(604)	(598)	(598)	(612)	(629)	(614)	(597)
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	467	(4 906)	(3 599)	646	(316)	(2 503)	(2 710)	0	(1 828)	(728)	(142)	0	(127)	(6 542)	(111)	0	(5 907)	(5 907)	(5 907)	0	(13 866)	(13 932)	(13 932)	0	(66)	0	(3)	0	0	(271)	3	0	(2 428)	(2 428)	(2 356)	0	(4 474)	0	0	0	0	0	0	0	(46)	(45)	(45)	0	0	0	0	0	0	0	0	0	0	(20)	0	0	54	0	0	0
Operating Income	4 823 N/A	3 726 -23%	3 438 -8%	4 800 +40%	3 581 -25%	3 061 -15%	1 556 -49%	629 -60%	(1 625) N/A	(695) +57%	(738) -6%	(383) +48%	1 149 N/A	2 393 +108%	3 273 +37%	3 145 -4%	4 018 +28%	4 359 +8%	4 025 -8%	5 347 +33%	7 957 +49%	6 077 -24%	(370) N/A	(3 734) -909%	(6 604) -77%	(12 134) -84%	(7 989) +34%	(5 195) +35%	(3 064) +41%	(4 158) -36%	(5 008) -20%	(9 503) -90%	(12 982) -37%	(17 054) -31%	(14 209) +17%	(10 604) +25%	815 N/A	(12 994) N/A	(13 526) -4%	(16 123) -19%	(4 280) +73%	(4 198) +2%	(3 656) +13%	(2 041) +44%	285 N/A	(2 205) N/A	(2 825) -28%	398 N/A	3 540 +789%	2 240 -37%	3 589 +60%	3 735 +4%	5 473 +47%	3 275 -40%	13 149 +301%	15 548 +18%	17 090 +10%	17 381 +2%	11 991 -31%	8 492 -29%	5 935 -30%	8 443 +42%	8 400 -1%	9 575 +14%	10 099 +5%	4 112 -59%	3 222 -22%	1 637 -49%	1 506 -8%	359 -76%	7 800 +2 071%	7 269 -7%	2 211 -70%	4 068 +84%	(7 131) N/A	(6 772) +5%	230 N/A	(229) N/A	3 920 N/A	3 839 -2%	(916) N/A
Pre-Tax Income
Interest Income Expense	(520)	(446)	(565)	(593)	(1 037)	(1 023)	(871)	(831)	(458)	1 756	1 711	1 583	1 242	(1 688)	(1 956)	(2 291)	(2 361)	(2 266)	(2 799)	(3 042)	(4 024)	(3 711)	(4 472)	(4 262)	(6 753)	(3 010)	(1 897)	(1 591)	(1 411)	(1 314)	(1 094)	(736)	(619)	(492)	(441)	9	(101)	252	213	(307)	166	222	665	1 036	974	1 023	1 004	1 020	904	985	2 170	2 213	2 747	2 986	2 138	2 633	2 409	2 099	6 314	6 102	13 127	13 008	8 402	7 939	401	802	596	524	635	802	1 250	2 108	2 566	1 864	1 416	823	189	128	305	(152)	(4 223)
Non-Reccuring Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(313)	0	0	(1 629)	4	0	0	0	0	0	(16)	(126)	0	0	0	(5 905)	0	0	0	(13 864)	0	0	0	(78)	(19)	(32)	(165)	(279)	(285)	0	(212)	(2 441)	0	0	0	(4 473)	0	(6 740)	(6 740)	(2 267)	(2 266)	0	0	(44)	0	0	0	1	0	0	0	0	(9)	(9)	7	(30)	(20)	0	(37)	54	0	55	72	(259)
Gain/Loss on Disposition of Assets	(2 113)	(1 651)	(1 070)	(916)	(759)	(566)	(611)	(660)	(446)	(523)	(776)	(645)	(656)	(688)	(568)	(640)	(1 200)	0	0	0	0	0	0	0	(212)	0	0	0	619	0	0	13	13	0	0	5	5	0	0	(131)	(67)	(145)	(40)	152	150	167	0	286	285	0	288	3	3	12	0	9	9	1	(15)	0	(14)	(1 021)	0	(1 051)	(1 052)	(47)	(30)	16	17	0	0	(4)	(9)	(225)	(232)	(457)	(453)	0	(230)	17	23
Total Other Income	(292)	(103)	(28)	96	(234)	(192)	(300)	(17)	632	352	407	190	(36)	105	251	816	957	(175)	(80)	(509)	0	0	0	0	(99)	685	637	604	9	137	465	(1 187)	(1 086)	(626)	(1 269)	111	388	(222)	257	598	(566)	(574)	(410)	(115)	543	738	521	193	339	533	300	296	246	292	321	345	214	135	82	(84)	222	140	(821)	(46)	(747)	(706)	(859)	(574)	(228)	(197)	(351)	(915)	(1 536)	(1 534)	(1 300)	(779)	(204)	(452)	(471)	(389)	(805)
Pre-Tax Income	1 899 N/A	1 528 -20%	1 776 +16%	3 389 +91%	1 551 -54%	1 281 -17%	(226) N/A	(880) -289%	(1 897) -116%	889 N/A	602 -32%	743 +23%	1 700 +129%	122 -93%	998 +718%	1 029 +3%	1 413 +37%	1 605 +14%	1 146 -29%	1 796 +57%	2 303 +28%	2 370 +3%	(4 842) N/A	(7 996) -65%	(13 668) -71%	(14 458) -6%	(9 248) +36%	(6 197) +33%	(3 973) +36%	(5 335) -34%	(5 637) -6%	(11 415) -103%	(20 580) -80%	(18 172) +12%	(15 919) +12%	(10 479) +34%	(12 757) -22%	(12 964) -2%	(13 056) -1%	(15 963) -22%	(4 825) +70%	(4 714) +2%	(3 474) +26%	(1 135) +67%	1 674 N/A	(562) N/A	(1 300) -131%	1 685 N/A	2 627 +56%	3 758 +43%	6 348 +69%	6 247 -2%	3 996 -36%	6 564 +64%	8 868 +35%	11 794 +33%	17 455 +48%	17 351 -1%	18 373 +6%	14 510 -21%	19 225 +32%	20 570 +7%	15 981 -22%	16 418 +3%	8 702 -47%	4 162 -52%	2 929 -30%	1 603 -45%	1 929 +20%	955 -50%	8 690 +810%	8 466 -3%	3 203 -62%	4 153 +30%	(7 247) N/A	(7 222) +0%	(183) +97%	(553) -202%	3 581 N/A	3 387 -5%	(6 180) N/A
Net Income
Tax Provision	(1 151)	(1 012)	(946)	(1 463)	(1 165)	(1 176)	(793)	(820)	867	134	187	644	(530)	97	(408)	(408)	(831)	(832)	(710)	(710)	(1 620)	(1 621)	(412)	(412)	(858)	(858)	(1 608)	(1 608)	1 050	925	1 435	1 435	(919)	(795)	(1 215)	(1 215)	99	99	(87)	(87)	(2 252)	(2 429)	(2 343)	(2 343)	352	530	475	513	3 187	3 187	2 801	2 753	(696)	(683)	(1 496)	(1 515)	1 719	2 402	3 084	5 204	539	(157)	1 797	(294)	194	126	(1 979)	(1 979)	(1 678)	(1 875)	(2 226)	(2 418)	306	285	1 056	934	(1 622)	(1 136)	(1 347)	(1 077)	621
Income from Continuing Operations	749	516	831	1 927	386	105	(1 018)	(1 698)	(1 030)	1 025	790	1 387	1 170	219	591	622	582	775	438	1 088	683	750	(5 254)	(8 408)	(14 526)	(15 317)	(10 857)	(7 806)	(2 924)	(4 409)	(4 200)	(9 978)	(21 499)	(18 966)	(17 134)	(11 694)	(12 658)	(12 865)	(13 143)	(16 050)	(7 077)	(7 143)	(5 817)	(3 478)	2 026	(32)	(825)	2 198	5 813	6 945	9 149	9 000	3 300	5 882	7 373	10 280	19 174	19 753	21 458	19 715	19 764	20 414	17 778	16 124	8 896	4 288	949	(376)	251	(919)	6 464	6 049	3 509	4 439	(6 191)	(6 288)	(1 805)	(1 689)	2 233	2 310	(5 559)
Net Income (Common)	749 N/A	516 -31%	831 +61%	1 927 +132%	386 -80%	105 -73%	(1 018) N/A	(1 698) -67%	(1 030) +39%	1 025 N/A	790 -23%	1 387 +76%	1 170 -16%	219 -81%	591 +170%	622 +5%	582 -6%	775 +33%	438 -43%	1 088 +148%	683 -37%	750 +10%	(5 254) N/A	(8 408) -60%	(14 526) -73%	(15 317) -5%	(10 857) +29%	(7 806) +28%	(2 924) +63%	(4 409) -51%	(4 200) +5%	(9 978) -138%	(21 499) -115%	(18 966) +12%	(17 134) +10%	(11 694) +32%	(12 658) -8%	(12 865) -2%	(13 143) -2%	(16 050) -22%	(7 077) +56%	(7 143) -1%	(5 817) +19%	(3 478) +40%	2 026 N/A	(32) N/A	(825) -2 478%	2 198 N/A	5 813 +164%	6 945 +19%	9 149 +32%	9 000 -2%	3 300 -63%	5 882 +78%	7 373 +25%	10 280 +39%	19 174 +87%	19 753 +3%	21 458 +9%	19 715 -8%	19 764 +0%	20 414 +3%	17 778 -13%	16 124 -9%	8 896 -45%	4 288 -52%	949 -78%	(376) N/A	251 N/A	(919) N/A	6 464 N/A	6 049 -6%	3 509 -42%	4 439 +27%	(6 191) N/A	(6 288) -2%	(1 805) +71%	(1 689) +6%	2 233 N/A	2 310 +3%	(5 559) N/A
EPS (Diluted)	25.82 N/A	17.79 -31%	28.65 +61%	56.67 +98%	12.45 -78%	3.08 -75%	-29.08 N/A	-49.94 -72%	-30.29 +39%	29.28 N/A	22.57 -23%	39.62 +76%	33.42 -16%	6.44 -81%	17.38 +170%	17.27 -1%	17.11 -1%	22.14 +29%	12.51 -43%	31.08 +148%	19.51 -37%	21.42 +10%	-150.11 N/A	-233.55 -56%	-415.02 -78%	-425.47 -3%	-293.43 +31%	-210.97 +28%	-79.02 +63%	-110.22 -39%	-102.43 +7%	-243.36 -138%	-524.36 -115%	-474.15 +10%	-428.35 +10%	-292.35 +32%	-316.45 -8%	-321.62 -2%	-262.86 +18%	-341.48 -30%	-160.84 +53%	-140.05 +13%	-114.05 +19%	-68.19 +40%	39.72 N/A	-0.62 N/A	-16.17 -2 508%	43.09 N/A	113.98 +165%	136.17 +19%	179.39 +32%	176.47 -2%	64.7 -63%	115.33 +78%	144.56 +25%	201.56 +39%	375.96 +87%	387.31 +3%	420.74 +9%	386.56 -8%	387.52 +0%	400.27 +3%	347.2 -13%	314.88 -9%	173.74 -45%	83.78 -52%	18.72 -78%	-7.41 N/A	4.95 N/A	-18.14 N/A	127.52 N/A	119.33 -6%	69.21 -42%	87.57 +27%	-122.12 N/A	-124 -2%	-35.59 +71%	-33.24 +7%	43.97 N/A	45.01 +2%	-109.48 N/A

Income Statement Balance Sheet Cash Flow Statement

Hanall Biopharma Co Ltd
KRX:009420

Income Statement

Earnings Waterfall
Hanall Biopharma Co Ltd

Income Statement
Hanall Biopharma Co Ltd

See Also

Company

Help

Tools

Stocks

Hanall Biopharma Co Ltd KRX:009420

Income Statement

Earnings Waterfall Hanall Biopharma Co Ltd

Income Statement Hanall Biopharma Co Ltd

See Also

Company

Help

Tools

Stocks

Hanall Biopharma Co Ltd
KRX:009420

Earnings Waterfall
Hanall Biopharma Co Ltd

Income Statement
Hanall Biopharma Co Ltd